483P Prognostic value of androgen receptor expression in patients with advanced triple-negative metastatic breast cancer treated with sacituzumab govitecan: A French multicentre retrospective study

• DOI: 10.1016/j.annonc.2023.09.659
• Publication Date: 2023-10-20T11:36:57Z
• Authors: M. Arnedos; B. Segier; N. Vincent; M. Robert; T. Grinda; T. Grellety; E. Deluche; J. Lehmann-Che; W. Jacot; M-F. Heymann; A. Lusque; M. Brunet; L. Teixeira; S. Guiu
• Keywords: Triple-negative breast cancer; Clinical endpoint; Progression-free survival